BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
SNCA
,
cell-cell adhesion
,
Ischemia
,
Heart
,
Avian flu virus
,
Lipitor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
substance P receptors
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Advances in the research and application of neurokinin-1 receptor antagonists.
Illuminating the structural basis of human neurokinin 1 receptor (NK1R) antagonism through classical…
The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Chall…
Identification of an Intravenous Injectable NK1 Receptor Antagonist for Use in Traumatic Brain Injur…
Neurokinin 1 Receptor Antagonists for Pruritus.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Findi…
Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With […
Regional Anaesthesia and Substance P in Head and Neck Cancer
Differentiating the Effects of Substance P and Beta-endorphin
Effects of Substance P Antagonists on Adrenal Secretion
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ